What is a taxol?

Taxol is a trade mark for Paclitaxel, a drug used to treat cancer range. Bristol-Mysers Squibb (BMS) currently manages the rights to Paclitaxel. This medicine can be very effective for some cancer patients, although it is also very expensive and not shaped by all insurance programs. In some regions, patients may be asked to pay for their own taxol, which significantly contributes to the costs of cancer treatment. When connected with chemotherapy, radiation and other cancer treatments, Taxol can help reduce cancer and eventually remove them from the body. Sometimes it is also prescribed as a long -term treatment of surviving cancer, which inhibits cancer recurrence in critical years after cancer treatment. The drug is used to treat lungs, ovaries, breast, head/neck, bladder, prostate and esophageal cancer, along with Kaposi's sarcoma.

This medicine was discovered by the National Institute for Cancer in UnitedStates in 1967. BMS received the rights to Taxol after contributing to the research of the drug and helped with the calculations of the benefit. The assignment of the Taxol rights was considered controversial because some people believe that BMS has significantly benefited from the discovery of a government agency that benefits the US people, not for pharmaceuticals. Others point out that BMS has contributed to the development of a drug of significant funds, including funds used to develop a semi -synthetic form of taxol, and therefore the company has the right to recruit its investment.

Initially, Taxol was developed from the Pacific Tisus. Later, other thousands proved to be valuable sources of drugs, and scientists BMS found that this could be synthesized from the compounds present in Thjeheli many Tiso trees, allowing society to produce taxol without damage to forests. In pure form, taxol is white powder. The drug is provided in the form of a liquid that must be injected or inflated into patients.

Because taxol is irritating, it must be injected carefully, thereforeE may cause inflammation around the injection site. Many patients also experience allergic reactions, so it is common to prescribe drugs that prevent this when taxol is administered.

various side effects are associated with taxol, including swelling, nausea, hair loss, joint pain, skin darkening, nails, low blood, mouth ulcers and hypersensitivity. Combined with other symptoms related to cancer treatment, taxol can make patients quite unpleasant and people are often recommended to relax after taxol infusion and prevent strenuous activity.